Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Bacterial Lysate to Prevent Persistent Wheeze in Infants After Severe Bronchiolitis; a Randomised Placebo-controlled Trial

NCT05064631 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT05064631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05064631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Bacterial Lysate to Prevent Persistent Wheeze in Infants After Severe Bronchiolitis; a Randomised Placebo-controlled Trial
Lead sponsor
Queen Mary University of London
Phase
Phase 2
Overall status
Completed
Start date
January 12, 2022
Completion date
June 13, 2024
Enrollment
173 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric respiratory diseases, respiratory tract infections, wheezing